Owens & Minor buys ArcRoyal; ReWalk reimbursed by German insurer;

@FierceMedDev: Treasury's crackdown on inversion could scupper Medtronic-Covidien deal. More | Follow @FierceMedDev

@MichaelGFierce: Vaxxas' nanopatch garners WHO support in search of #polio vax application. Story via FierceDrugDelivery | Follow @MichaelGFierce

@VarunSaxena2: In case you're wondering, $MDT can cancel its deal with $COV without penalty if it's due to changes in the tax code. Wonder what will happen. | Follow @VarunSaxena2

@EmilyWFierce: T2 Biosystems wins FDA approval for sepsis diagnostic system. More | Follow @EmilyWFierce

> Healthcare logistics company Owens & Minor acquired Ireland-based surgical kitting company ArcRoyal for an undisclosed amount in an effort to expand its global reach. Release

> Inivita, a clinical cancer genomics company, raised £4 million ($6.56 million) in a funding round led by Imperial Innovations. Release

> A major German insurance company is the first to reimburse for the ReWalk System, a robotic exosuit for spinal cord injury patients that FDA approved recently. Release

> Indian regulators are seriously considering instituting a price cap on medical devices in response to countrywide complaints of price gauging and bribery in the medical device industry. News

Biotech News

@FierceBiotech: If you missed yesterday's live #Fierce15 announcement, catch the replay from @partnering360. Watch | Follow @FierceBiotech

@JohnCFierce: Fun watching the inversion news bend from "Oh no!" to "Hey, wait a minute" this morning. Maybe not the kiss of death after all? | Follow @JohnCFierce

@DamianFierce: Fierce15 winner Molecular Partners just filed to raise ~$134M in a Swiss IPO. | Follow @DamianFierce

> Fast-tracked Ebola studies put Tekmira, Mapp and Sarepta in the spotlight. News

> Biogen shoulders into gene therapy amid a second honeymoon for the field. More

> NEA pitches in on a $27M gamble on Tracon's mid-stage cancer drug program. Story

> Who loses in biopharma as Treasury moves to block tax inversions? Article

Pharma News

@FiercePharma: Allergan rebuffed Actavis bid, saying it's 'closing in' on a $10B-plus Salix buy. Story | Follow @FiercePharma

@EricPFierce: Mylan proposes plan to avoid nitroglycerin shortage in Canada. Article via FiercePharmaManufacturing | Follow @EricPFierce

> Faltering Boehringer slashes 600 jobs in Germany in bid to save $580M. Story

> Heads will roll at GlaxoSmithKline, investors say. The question is, whose? Article

> Tax-deal crackdown's victims, say analysts? Mylan and Abbott, not Pfizer and AZ. News

Biotech Research News

> Researchers develop tumor-on-a-chip to test new cancer drugs. Article

> Genetic 'switch' may control aging process. News

> Drug development for tropical diseases gets $15.3M boost. Item

> Pathway discovery reveals another potential Alzheimer's drug target. Article

> New technique generates stem cells at highly efficient rate. Story

Pharma Manufacturing News

> GSK accidentally dumps 'liquid contaminated with poliovirus' into Belgian sewer system. Report

> Ritedose to invest up to $110M in South Carolina plant. Article

> Recall of Mylan nitroglycerin revised to avoid shortage. Story

> GSK influenza plant in Texas on track to start up in 2016. Item

> Merck KGaA deal for Sigma-Aldrich gets it some specialty manufacturing capacity. More

Suggested Articles

Flatiron has hired a new chief medical officer as it looks to push on under its new parent in the world of electronic health records and real-world data.

Saga Diagnostics has raised 40 million Swedish kronor, or about $4.1 million, to help develop its ultrasensitive cancer liquid biopsy tests.

Terumo will help Orchestra BioMed develop its sirolimus-eluting balloon in both coronary and peripheral cardiovascular interventions.